Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aneurismal subarachnoid hemorrhage during the COVID-19 outbreak in a Hub and Spoke system: observational multicenter cohort study in Lombardy, Italy.
Fiorindi A, Vezzoli M, Doglietto F, Zanin L, Saraceno G, Agosti E, Barbieri A, Bellocchi S, Bernucci C, Bongetta D, Cardia A, Costi E, Egidi M, Fioravanti A, Gasparotti R, Giussani C, Grimod G, Latronico N, Locatelli D, Mardighian D, Nodari G, Poli JC, Rasulo F, Roca E, Sicuri GM, Spena G, Stefini R, Vivaldi O, Zoia C, Calza S, Fontanella MM, Cenzato M. Fiorindi A, et al. Among authors: barbieri a. Acta Neurochir (Wien). 2022 Jan;164(1):141-150. doi: 10.1007/s00701-021-05013-9. Epub 2021 Oct 25. Acta Neurochir (Wien). 2022. PMID: 34694465 Free PMC article.
PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
Palma G, Pasqua T, Silvestri G, Rocca C, Gualtieri P, Barbieri A, De Bartolo A, De Lorenzo A, Angelone T, Avolio E, Botti G. Palma G, et al. Among authors: barbieri a. Front Immunol. 2020 Aug 21;11:2094. doi: 10.3389/fimmu.2020.02094. eCollection 2020. Front Immunol. 2020. PMID: 32973818 Free PMC article. Review.
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Quagliariello V, et al. Among authors: barbieri a. Front Cardiovasc Med. 2022 Sep 8;9:930797. doi: 10.3389/fcvm.2022.930797. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158826 Free PMC article.
β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism.
Mele L, Del Vecchio V, Marampon F, Regad T, Wagner S, Mosca L, Bimonte S, Giudice A, Liccardo D, Prisco C, Schwerdtfeger M, La Noce M, Tirino V, Caraglia M, Papaccio G, Desiderio V, Barbieri A. Mele L, et al. Among authors: barbieri a. Cell Death Dis. 2020 Oct 13;11(10):850. doi: 10.1038/s41419-020-03056-x. Cell Death Dis. 2020. PMID: 33051434 Free PMC article.
MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response.
Tagliamonte M, Mauriello A, Cavalluzzo B, Ragone C, Manolio C, Luciano A, Barbieri A, Palma G, Scognamiglio G, Di Mauro A, Di Bonito M, Tornesello ML, Buonaguro FM, Vitagliano L, Caporale A, Ruvo M, Buonaguro L. Tagliamonte M, et al. Among authors: barbieri a. Front Immunol. 2021 Oct 20;12:769799. doi: 10.3389/fimmu.2021.769799. eCollection 2021. Front Immunol. 2021. PMID: 34745146 Free PMC article.
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N. Quagliariello V, et al. Among authors: barbieri a. Cardiovasc Diabetol. 2021 Jul 23;20(1):150. doi: 10.1186/s12933-021-01346-y. Cardiovasc Diabetol. 2021. PMID: 34301253 Free PMC article.
1,009 results